Search details
1.
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38538060
2.
Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis.
Clin Immunol
; 254: 109709, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37495004
3.
Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.
Cytotherapy
; 25(12): 1271-1276, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37737765
4.
Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb.
Cancer Cell Int
; 22(1): 389, 2022 Dec 08.
Article
in English
| MEDLINE | ID: mdl-36482431
5.
Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis.
Mult Scler
; 27(13): 2112-2115, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33870788
6.
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(5): 514-521, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30538138
7.
Incidence and prevalence of NMOSD in Australia and New Zealand.
J Neurol Neurosurg Psychiatry
; 88(8): 632-638, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28550069
8.
Neutropaenia complications from Ocrelizumab and Rituximab treatment.
Mult Scler Relat Disord
; 81: 105147, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38043368
9.
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Brain
; 135(Pt 5): 1622-38, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22539258
10.
From bedside to bench: how existing therapies inform the relationship between Epstein-Barr virus and multiple sclerosis.
Clin Transl Immunology
; 12(2): e1437, 2023.
Article
in English
| MEDLINE | ID: mdl-36844913
11.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol
; 80(7): 702-713, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-37437240
12.
Neuromyelitis optica: not a multiple sclerosis variant.
Curr Opin Neurol
; 25(3): 215-20, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22487568
13.
Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
Brain Res
; 1776: 147752, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34906547
14.
Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis.
Front Immunol
; 13: 798300, 2022.
Article
in English
| MEDLINE | ID: mdl-35197974
15.
Sustained immunotolerance in multiple sclerosis after stem cell transplant.
Ann Clin Transl Neurol
; 9(2): 206-220, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35106961
16.
Response to treatment in NMOSD: the Australasian experience.
Mult Scler Relat Disord
; 58: 103408, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35216788
17.
Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.
Front Immunol
; 12: 782935, 2021.
Article
in English
| MEDLINE | ID: mdl-35126353
18.
Galectin-3 protects against ischemic stroke by promoting neuro-angiogenesis via apoptosis inhibition and Akt/Caspase regulation.
J Cereb Blood Flow Metab
; 41(4): 857-873, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33736511
19.
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Front Neurol
; 12: 722237, 2021.
Article
in English
| MEDLINE | ID: mdl-34566866
20.
The clinical profile of NMOSD in Australia and New Zealand.
J Neurol
; 267(5): 1431-1443, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32006158